HCRT and Alzheimer disease: Studies on orexin, also known as hypocretin, (a molecule that regulates wakefulness, strongly implicated in sleep disorders) showed that its release from hypothalamic neurons and the pattern of Aβ in CSF have a comparable diurnal fluctuation, and that orexin itself shows a circadian rhythm in both AD patients and controls (56, 57).